Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review

CONTEXT: Most recently developed anti-hyperglycemic drugs have offered cardiovascular and renal benefits. In this narrative review, we discuss the cardiovascular and renal benefits of novel antidiabetic drugs, sodium glucose cotransporter type 2 (SGLT2) inhibitors, in type 2 diabetes. EVIDENCE ACQUI...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabizadeh, Soghra, Nakhjavani, Manouchehr, Esteghamati, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628616/
https://www.ncbi.nlm.nih.gov/pubmed/31372172
http://dx.doi.org/10.5812/ijem.84353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628616/
https://www.ncbi.nlm.nih.gov/pubmed/31372172
http://dx.doi.org/10.5812/ijem.84353

Ejemplares similares